guest ::
| Home > Publications database > 4-[18F]fluorophenyl ureas via carbamate-4-nitrophenyl esters and 4-[18F]fluoroaniline > print |
| Home > Publications database > 4-[18F]fluorophenyl ureas via carbamate-4-nitrophenyl esters and 4-[18F]fluoroaniline > print |
| 001 | 54737 | ||
| 005 | 20190625110611.0 | ||
| 024 | 7 | _ | |2 DOI |a 10.1002/jlcr.1121 |
| 024 | 7 | _ | |2 WOS |a WOS:000242335900002 |
| 024 | 7 | _ | |2 ISSN |a 0362-4803 |
| 024 | 7 | _ | |a altmetric:21816362 |2 altmetric |
| 037 | _ | _ | |a PreJuSER-54737 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 540 |
| 084 | _ | _ | |2 WoS |a Biochemical Research Methods |
| 084 | _ | _ | |2 WoS |a Chemistry, Medicinal |
| 084 | _ | _ | |2 WoS |a Chemistry, Analytical |
| 084 | _ | _ | |2 WoS |a Pharmacology & Pharmacy |
| 100 | 1 | _ | |0 P:(DE-Juel1)VDB43841 |a Olma, S. |b 0 |u FZJ |
| 245 | _ | _ | |a 4-[18F]fluorophenyl ureas via carbamate-4-nitrophenyl esters and 4-[18F]fluoroaniline |
| 260 | _ | _ | |a New York, NY [u.a.] |b Wiley |c 2006 |
| 300 | _ | _ | |a 1037 - 1050 |
| 336 | 7 | _ | |a Journal Article |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a article |2 DRIVER |
| 440 | _ | 0 | |0 3464 |a Journal of Labelled Compounds and Radiopharmaceuticals |v 49 |x 0362-4803 |
| 500 | _ | _ | |a Record converted from VDB: 12.11.2012 |
| 520 | _ | _ | |a Four different no carrier added (n.c.a.) 4-[F-18]fluorophenylurea derivatives are synthesized as model compounds via two alternative routes. In both cases carbamate-4-nitrophenylesters are used as intermediates. Either n.c.a. 4-[F-18]fluoroaniline reacts with carbamates of several amines, or the carbamate of n.c.a. 4-[F-18]fluoroaniline is formed at first and an amine is added subsequently to yield the urea derivative. The choice of the appropriate way of reaction depends on the possibilities of precursor synthesis. The radiochemical yields reach up to 80% after 50min of synthesis time while no radiochemical by-products can be determined. These high yields were possible due to an optimized preparation of n.c.a. 4-[F-18]fluoroaniline with a radiochemical yield of up to 90%. From the various ways of its radiosynthesis, the substitution with n.c.a. [F-18]fluoride on dinitrobenzene is chosen, using phosphorous acid and palladium black for reduction of the second nitro group. (c) Copyright 2006 John Wiley & Sons, Ltd. |
| 536 | _ | _ | |0 G:(DE-Juel1)FUEK409 |2 G:(DE-HGF) |a Funktion und Dysfunktion des Nervensystems |c P33 |x 0 |
| 588 | _ | _ | |a Dataset connected to Web of Science |
| 650 | _ | 7 | |2 WoSType |a J |
| 653 | 2 | 0 | |2 Author |a n.c.a. radiofluorination |
| 653 | 2 | 0 | |2 Author |a [F-18]fluorophenyl ureas |
| 653 | 2 | 0 | |2 Author |a [F-18]fluoroaniline |
| 653 | 2 | 0 | |2 Author |a carbamates |
| 700 | 1 | _ | |0 P:(DE-Juel1)VDB6242 |a Ermert, J. |b 1 |u FZJ |
| 700 | 1 | _ | |0 P:(DE-Juel1)131816 |a Coenen, H. H. |b 2 |u FZJ |
| 773 | _ | _ | |0 PERI:(DE-600)1491841-9 |a 10.1002/jlcr.1121 |g Vol. 49, p. 1037 - 1050 |n 12 |p 1037 - 1050 |q 49<1037 - 1050 |t Journal of labelled compounds and radiopharmaceuticals |v 49 |x 0362-4803 |y 2006 |
| 856 | 7 | _ | |u http://dx.doi.org/10.1002/jlcr.1121 |
| 909 | C | O | |o oai:juser.fz-juelich.de:54737 |p VDB |
| 913 | 1 | _ | |0 G:(DE-Juel1)FUEK409 |b Gesundheit |k P33 |l Funktion und Dysfunktion des Nervensystems |v Funktion und Dysfunktion des Nervensystems |x 0 |
| 914 | 1 | _ | |y 2006 |
| 915 | _ | _ | |a JCR/ISI refereed |0 StatID:(DE-HGF)0010 |2 StatID |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1150 |2 StatID |b Current Contents - Physical, Chemical and Earth Sciences |
| 920 | 1 | _ | |0 I:(DE-Juel1)VDB53 |d 31.12.2006 |g INC |k INC |l Institut für Nuklearchemie |x 0 |
| 970 | _ | _ | |a VDB:(DE-Juel1)85586 |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a ConvertedRecord |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a I:(DE-Juel1)INM-5-20090406 |
| 980 | _ | _ | |a UNRESTRICTED |
| 981 | _ | _ | |a I:(DE-Juel1)INM-5-20090406 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|